- Home
- MTEX vs TLPH Comparison
MTEX vs TLPH Comparison
Compare MTEX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- TLPH
- Stock Information
- Founded
- MTEX 1993
- TLPH 2005
- Country
- MTEX United States
- TLPH United States
- Employees
- MTEX N/A
- TLPH N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- TLPH Health Care
- Exchange
- MTEX Nasdaq
- TLPH Nasdaq
- Market Cap
- MTEX 13.6M
- TLPH 15.7M
- IPO Year
- MTEX 1999
- TLPH 2011
- Fundamental
- Price
- MTEX $7.63
- TLPH $0.80
- Analyst Decision
- MTEX
- TLPH Strong Buy
- Analyst Count
- MTEX 0
- TLPH 2
- Target Price
- MTEX N/A
- TLPH $4.50
- AVG Volume (30 Days)
- MTEX 5.1K
- TLPH 81.8K
- Earning Date
- MTEX 11-05-2024
- TLPH 11-06-2024
- Dividend Yield
- MTEX N/A
- TLPH N/A
- EPS Growth
- MTEX N/A
- TLPH N/A
- EPS
- MTEX N/A
- TLPH N/A
- Revenue
- MTEX $122,380,000.00
- TLPH $398,000.00
- Revenue This Year
- MTEX N/A
- TLPH N/A
- Revenue Next Year
- MTEX N/A
- TLPH N/A
- P/E Ratio
- MTEX N/A
- TLPH N/A
- Revenue Growth
- MTEX N/A
- TLPH 57.31
- 52 Week Low
- MTEX $6.75
- TLPH $0.43
- 52 Week High
- MTEX $10.51
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- MTEX 55.89
- TLPH 41.60
- Support Level
- MTEX $7.05
- TLPH $0.71
- Resistance Level
- MTEX $7.90
- TLPH $0.86
- Average True Range (ATR)
- MTEX 0.13
- TLPH 0.08
- MACD
- MTEX -0.01
- TLPH -0.01
- Stochastic Oscillator
- MTEX 73.40
- TLPH 35.68
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.